|Bid||0.00 x 900|
|Ask||0.00 x 1000|
|Day's range||138.04 - 139.37|
|52-week range||120.40 - 158.34|
|Beta (5Y monthly)||0.93|
|PE ratio (TTM)||10.48|
|Earnings date||19 Apr 2023 - 24 Apr 2023|
|Forward dividend & yield||2.84 (1.94%)|
|Ex-dividend date||06 Apr 2023|
|1y target est||150.13|
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.